Ran Chen Joins Pure Global as Chief Technology Officer

 Medtech regulatory consultancy Pure Global has appointed Ran Chen as its chief technology officer (CTO). With more than a decade of experience in machine learning and artificial intelligence (AI) product development, Chen will lead the company’s technology strategy as it expands its mission to simplify global market access (GMA) through intelligent automation.

The medical device industry faces increasing regulatory complexity, leading to long delays in registration and market entry. These timelines slow patient access to life-saving devices and are costly. Pure Global’s AI platform is helping manufacturers cut through these delays, and Chen’s appointment marks a key milestone in that effort, particularly around agentic AI—systems that automate tasks like translation, classification, and document generation to reduce bottlenecks and speed up submissions.

“With Ran as CTO, we’re accelerating our ability to build and scale the tools our clients need,” Pure Global Co-Founder/Chief Operating Officer D.J. Fang said. “The impact is already clear as our AI agents are showing strong results across translation, classification, and document building.”

Chen most recently served as director of Engineering for Machine Learning at Tubi TV, where he was the company’s first ML hire and built its entire machine learning infrastructure. Under his leadership, Tubi developed more than 70 real-time models that powered personalized content experiences, helping the platform grow into a top ad-supported U.S. video streaming service.

Related: Pure Global and MEDIcept Partner to Drive Medtech Growth, Innovation

As CTO, Chen will lead the development of Pure Global’s agentic AI capabilities and reinforce the underlying data infrastructure. His top priorities include accelerating the development of tools that support classification, translation, document generation, and gap analysis—all core steps in medical device registration. He’ll also work closely with clients to ensure the platform evolves with their needs and scales effectively across markets.

“I’m excited to join Pure Global and apply my machine learning experience to medical device regulation, a space where technology can make a real difference,” Chen stated. “My focus is on using agentic AI to reduce delays and simplify global market access. We build every tool with one goal in mind: helping our clients move faster with less friction.”

Chen’s appointment reinforces Pure Global’s focus on becoming a fully AI-driven company. Over the past two years, the company has also built a global market access infrastructure, establishing legal entities and partnerships in more than 30 strategic markets. This enables Pure Global to combine local regulatory expertise with AI agents, offering a smarter, more efficient way for medtech companies to scale.

With cross-industry experience and a track record of scaling AI in high-growth environments, Chen brings a fresh perspective to one of the sector’s most complex challenges. His leadership marks a key step in Pure Global’s mission to reshape regulatory operations and support faster, more reliable market access worldwide.

Pure Global is an AI-powered platform that simplifies and accelerates global market access for medical devices. Through intelligent automation, multilingual document processing, and data-driven decision-making, Pure Global empowers medtech innovators to navigate regulatory complexities with speed and confidence.